What is Hepalink worth....I'm tired of checking back on slide presentations but I seem to recall that the Jan or Feb slide deck had Hepalink's Market Cap pegged at either $1 or $2 billion USD.

Okay I just checked back, the MC is pegged at $3.1 billion USD.  According to the WSJ site Hepalink is earnings positive, (0.51 EPS for 2018 but I don't know if that's USD or Renmimbi) and yet their MC is only a little better than half of what Amarin is worth.  Amarin of course has reported negative earnings,  losing $0.37 per share for the trailing 12 months and currently has close to 300 million shares outstanding.  

I figure Hepalink must look at the valuations North American listed companies trade at....and they have to be absolutely drooling.  

Call it positive racism if you will, but I happen to regard the Chinese as being very business savvy.  And the thought I can't let go of is that the end game here might be some kind of reverse merger to get them listed on an exchange like the Nasdaq.

I know some have commented that Hepalink doesn't have the footprint needed to properly market a drug like Apabetalone....but then nothing would say they'd have to do it alone.  They already have distribution deals with BP players like Sanofi and Novartis for their Heparin Sodium after all.

If they got their hands on Apabetalone what would prevent them from expanding those distribution agreements to include 208?  

If Apabetalone ends up treating all the indications it shows promise in....I can't begin to fathom the amount of revenue and profits it might generate....if Hepalink is getting frequent (daily?) updates on how things are progressing I'd imagine they have a better idea....